Our current study demonstrates that SLC7A11 mRNA methylation and degradation are reduced in response to cisplatin treatment, contributing to a rapid increase in SLC7A11 antiporter level that mitigates ferroptosis and promotes survival of BC cells. This evidence concerns the gene SLC7A11 and breast cancer.